Picamilon


Niacin-GABA conjugate

A Soviet-developed niacin-GABA conjugate (N-nicotinoyl-GABA) that crosses the blood-brain barrier and dissociates centrally to release both components.

Abstract

Picamilon (Pikamilon; N-nicotinoyl-GABA; CAS 34562-97-5; molecular formula C10H12N2O3; molecular weight 208.21) is a conjugate of niacin (nicotinic acid) and GABA developed in the Soviet Union in the 1970s. The niacin moiety provides blood-brain barrier permeability that GABA lacks; central hydrolysis releases both components. Niacin produces vasodilation and the GABA produces anxiolytic and mild sedative effects. The combination is approved in Russia for cerebrovascular insufficiency, anxiety, and migraine prophylaxis. Pharmacokinetics: rapid oral absorption; central hydrolysis to niacin and GABA; the niacin component is hepatically conjugated and excreted while GABA is metabolized through normal GABA pathways. The compound is sold as a research chemical/supplement in the United States though FDA has issued warnings against its sale as a dietary supplement.

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.


Browse all monographs

Previous monograph
Next monograph